Clinical performance evaluation of SARS-CoV-2 rapid antigen testing in point of care usage in comparison to RT-qPCR

Background: Antigen rapid diagnostic tests (RDT) for SARS-CoV-2 are fast, broadly available, and inexpensive. Despite this, reliable clinical performance data from large field studies is sparse. Methods: In a prospective performance evaluation study, RDT from three manufacturers (NADAL®, Panbio™, ME...

Descripción completa

Detalles Bibliográficos
Autores principales: Wagenhäuser, Isabell, Knies, Kerstin, Rauschenberger, Vera, Eisenmann, Michael, McDonogh, Miriam, Petri, Nils, Andres, Oliver, Flemming, Sven, Gawlik, Micha, Papsdorf, Michael, Taurines, Regina, Böhm, Hartmut, Forster, Johannes, Weismann, Dirk, Weißbrich, Benedikt, Dölken, Lars, Liese, Johannes, Kurzai, Oliver, Vogel, Ulrich, Krone, Manuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8234263/
https://www.ncbi.nlm.nih.gov/pubmed/34186490
http://dx.doi.org/10.1016/j.ebiom.2021.103455

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8234263/
https://www.ncbi.nlm.nih.gov/pubmed/34186490
http://dx.doi.org/10.1016/j.ebiom.2021.103455

Ejemplares similares